Hoitt Jason
Insider CIK 1762572 · STOK Chief Patient Officer · DOVA Chief Commercial Officer · PRVB Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 30 | $32.85 | $986 | 10,276 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 1,762 | $31.28 | $55.1K | 10,445 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 139 | $31.79 | $4.4K | 10,306 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 1,033 | $32.74 | $33.8K | 12,955 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 748 | $33.38 | $25.0K | 12,207 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | M Exercise deriv | 2026-03-15 | 2026-03-17 | 10,000 | — | $0 | 30,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | M Exercise | 2026-03-15 | 2026-03-17 | 10,000 | — | $0 | 13,988 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 48,000 | — | $0 | 48,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 72,000 | — | $0 | 72,000 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 137,750 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 400,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 200,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | S Sale | 2023-02-10 | 2023-02-14 | 4,500 | $10.00 | $45.0K | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2023-01-10 | 2023-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-12-08 | 2022-12-09 | 120,000 | — | $0 | 340,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-12-08 | 2022-12-09 | 20,663 | — | $0 | 75,763 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| PRVB Provention Bio, Inc. | P Buy | 2020-03-19 | 2020-03-20 | 4,500 | $5.43 | $24.4K | 4,500 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2020-01-07 | 2020-01-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 250,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer | 2019-11-12 | 2019-11-12 | 9,970 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-09-30 | 2019-10-02 | 2,387 | $28.00 | $66.8K | 9,970 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-07-15 | 2019-07-16 | 900 | $16.44 | $14.8K | 12,357 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-07-15 | 2019-07-16 | 6,680 | $15.10 | $100.9K | 13,257 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-06-28 | 2019-07-02 | 150 | $14.40 | $2.2K | 19,937 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-06-28 | 2019-07-02 | 2,237 | $13.77 | $30.8K | 20,087 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-04-08 | 2019-04-10 | 2,387 | $8.77 | $20.9K | 22,324 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award deriv | 2018-12-19 | 2018-12-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award | 2018-12-19 | 2018-12-20 | 24,711 | — | $0 | 24,711 | SEC↗ |